Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

SHA:688198 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	589.66	500.26	369.91	295.07	251.8	181.9
Other Revenue	1.61	1.61	0.73	0.1	0.02	0.02
Revenue	591.28	501.88	370.64	295.17	251.82	181.92
Revenue Growth (YoY)	45.79%	35.41%	25.57%	17.21%	38.42%	24.57%
Cost of Revenue	70.27	58.52	37.64	31.36	29.61	20.21
Gross Profit	521.01	443.35	333	263.81	222.21	161.71
Selling, General & Admin	187.6	154.92	131.97	123.77	131.16	83.41
Research & Development	160.06	151.44	98.81	55.15	58.9	28.77
Other Operating Expenses	-6.95	3.46	1.25	1.62	1.17	1.06
Operating Expenses	343.42	312.22	233.5	181.64	192.04	114.69
Operating Income	177.59	131.14	99.5	82.17	30.17	47.02
Interest Expense	-1.02	-0.46	-0.41	-0.08	-0.12	-
Interest & Investment Income	13.7	17.32	17.66	22.53	16.49	19.55
Currency Exchange Gain (Loss)	0.05	0.05	-0.26	0	-	-
Other Non Operating Income (Expenses)	2.03	-0.16	-0.06	-0.68	-0.05	-0.06
EBT Excluding Unusual Items	192.36	147.89	116.43	103.94	46.5	66.51
Gain (Loss) on Sale of Investments	0.35	0.74	1	0.89	0.97	0.34
Gain (Loss) on Sale of Assets	-0.05	-0.05	0.05	-0.01	-0.02	0.01
Other Unusual Items	-3.55	2.2	2.54	1.32	2.31	-0.57
Pretax Income	189.11	150.79	120.02	106.14	49.76	66.29
Income Tax Expense	23.85	18.64	10.61	11.74	-1.51	10.37
Earnings From Continuing Operations	165.27	132.14	109.41	94.39	51.26	55.92
Minority Interest in Earnings	15.07	14.19	5.8	0.73	-0.06	0.61
Net Income	180.33	146.33	115.21	95.13	51.2	56.53
Net Income to Common	180.33	146.33	115.21	95.13	51.2	56.53
Net Income Growth	74.15%	27.02%	21.11%	85.80%	-9.42%	-10.40%
Shares Outstanding (Basic)	138	137	136	136	135	134
Shares Outstanding (Diluted)	138	137	137	136	135	134
Shares Change (YoY)	1.25%	-0.29%	0.92%	0.86%	0.44%	33.66%
EPS (Basic)	1.31	1.07	0.85	0.70	0.38	0.42
EPS (Diluted)	1.31	1.07	0.84	0.70	0.38	0.42
EPS Growth	72.00%	27.38%	20.00%	84.21%	-9.82%	-32.96%
Free Cash Flow	94.52	-27.02	12.53	24.01	4.27	43.07
Free Cash Flow Per Share	0.68	-0.20	0.09	0.18	0.03	0.32
Dividend Per Share	0.800	0.800	0.800	0.500	0.357	0.143
Dividend Growth	-	-	60.00%	40.02%	149.90%	-
Gross Margin	88.11%	88.34%	89.84%	89.38%	88.24%	88.89%
Operating Margin	30.04%	26.13%	26.85%	27.84%	11.98%	25.85%
Profit Margin	30.50%	29.16%	31.08%	32.23%	20.33%	31.07%
Free Cash Flow Margin	15.98%	-5.38%	3.38%	8.14%	1.70%	23.67%
EBITDA	202.99	150.45	110.7	87.78	36.19	52.69
EBITDA Margin	34.33%	29.98%	29.87%	29.74%	14.37%	28.96%
D&A For EBITDA	25.4	19.31	11.19	5.61	6.02	5.67
EBIT	177.59	131.14	99.5	82.17	30.17	47.02
EBIT Margin	30.04%	26.13%	26.85%	27.84%	11.98%	25.85%
Effective Tax Rate	12.61%	12.36%	8.84%	11.06%	-	15.64%
Revenue as Reported	591.28	501.88	370.64	295.17	251.82	181.92
Advertising Expenses	-	2.01	0.37	1.12	1.22	0.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.